Clinical Trials Directory

Trials / Completed

CompletedNCT03781999

The Effect of a Combination of Orange- and Pomegranate Actives on Physical Fitness in Elderly People

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
37 (actual)
Sponsor
BioActor · Industry
Sex
All
Age
60 Years – 75 Years
Healthy volunteers
Accepted

Summary

The primary objective of this study is to determine the effect of daily supplementation of a combined orange- and pomegranate extract for a period of 4 weeks on physical fitness compared to placebo. In this crossover study, participants will daily receive either a placebo or Actiful®, a supplement containing 500 mg orange extract and 200 mg pomegranate actives, for 4 weeks followed by a wash-out period of 4 to 8 weeks. Subsequently, the second intervention period of 4 weeks (active product or placebo) will take place. The product and placebo will be supplied in capsules that participants can ingest with a glas of water (daily, prior to breakfast).

Detailed description

Dietary habits and physical activity are two important components of a healthy lifestyle. Targeted nutritional interventions may improve health and stimulate physical activity. Both orange extracts and pomegranate concentrate have been shown to exert beneficial effects on health and exercise performance. However, the effects of a combination of the two extracts on exercise and physical activity have not been investigated yet. It is expected that this combination may be an effective dietary way to improve exercise performance, physical activity in the free-living state, and quality of life in a middle aged population.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTActifulsupplement containing 500 mg orange extract and 200 mg pomegranate actives
OTHERPlaceboMaltodextrin

Timeline

Start date
2018-06-25
Primary completion
2019-01-17
Completion
2019-01-17
First posted
2018-12-20
Last updated
2019-06-24

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT03781999. Inclusion in this directory is not an endorsement.